Abstract
Background: Chronic obstructive pulmonary disease (COPD) patients are very sensitive to changes in pulmonary mechanics and central ventilation control during sleep and may develop significant gas exchange alterations with increased hypoxemia and hypercapnia. Oxygen therapy improves nocturnal desaturation but can worsen hypoventilation. Objectives: To analyze the prevalence of nocturnal hypoventilation (NHV) in hypercapnic COPD patients and to determine predictive factors for this phenomenon. Methods: This was a prospective multicenter study which enrolled 80 clinically stable COPD patients with hypercapnic respiratory failure who fulfilled the conventional criteria for long-term oxygen therapy (LTOT). All patients had undergone pulmonary function testing, blood gas analysis, and respiratory polygraphy. Arterial blood gas samples were obtained while patients were awake and during sleep. NHV was considered when an increase in PaCO2 >10 mm Hg was observed in any nocturnal arterial blood gas sample as compared to the awake levels. Results: Seventeen patients (21%) developed NHV. NHV was associated with the values of BMI, hemoglobin, hematocrits, DLCO, and PaO2 reached after oxygen administration. In the logistic regression analysis BMI (OR 1.26, 95% CI 1.068–1.481; p = 0.006) and the diurnal increase of PaO2 after O2 (OR 0.89, 95% CI 0.807–0.972; p = 0.010) were the variables that best discriminated with a sensitivity of 82% and a specificity of 78%. Conclusions: NHV is a relatively common finding in stable hypercapnic COPD patients undergoing LTOT and it is related to a higher BMI and lower PaO2 after oxygen administration.
Journal Section:
Editor's choice
References
1.
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980;93:391–398.
2.
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema: report of the Medical Research Council Working Party. Lancet 1981;1:681–686.
[PubMed]
3.
Fletcher EC, Levin DC: Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease: the effect of short- and long-term oxygen. Chest 1984;85:6–14.
[PubMed]
4.
Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A: Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985;131:493–498.
[PubMed]
5.
Zielinski J, Tobiasz M, Hawrylkiewicz I, Sliwinski P, Palasiewicz G: Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest 1998;113:65–70.
[PubMed]
6.
Morrison DA, Stovall JR: Increased exercise capacity in hypoxemic patients after long-term oxygen therapy. Chest 1992;102:542–550.
[PubMed]
7.
Krop HD, Block AJ, Cohen E: Neuropsychologic effects of continuous oxygen therapy in chronic obstructive pulmonary disease. Chest 1973;64:317–322.
[PubMed]
8.
McNicholas WT: Impact of sleep in COPD. Chest 2000;117:48S–53S.
[PubMed]
9.
Collop N: Sleep and sleep disorders in chronic obstructive pulmonary disease. Respiration 2010;80:78–86.
[PubMed]
10.
Cooper CB, Waterhouse J, Howard P: Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax 1987;42:105–110.
[PubMed]
11.
Cooper CB, Howard P: An analysis of sequential physiologic changes in hypoxic cor pulmonale during long-term oxygen therapy. Chest 1991;100:76–80.
[PubMed]
12.
Strom K, Boman G: Long-term oxygen therapy in parenchymal lung diseases: an analysis of survival. The Swedish Society of Chest Medicine. Eur Respir J 1993;6:1264–1270.
[PubMed]
13.
Foucher P, Baudouin N, Merati M, et al: Relative survival analysis of 252 patients with COPD receiving long-term oxygen therapy. Chest 1998;113:1580–1587.
[PubMed]
14.
Orchard CH, Kentish JC: Effects of changes of pH on the contractile function of cardiac muscle. Am J Physiol 1990;258:C967–C981.
[PubMed]
15.
Kiely DG, Cargill RI, Lipworth BJ: Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans. Chest 1996;109:1215–1221.
[PubMed]
16.
Juan G, Calverley P, Talamo C, Schnader J, Roussos C: Effect of carbon dioxide on diaphragmatic function in human beings. N Engl J Med 1984;310:874–879.
[PubMed]
17.
Douglas NJ, White DP, Weil JV, Pickett CK, Zwillich CW: Hypercapnic ventilatory response in sleeping adults. Am Rev Respir Dis 1982;126:758–762.
[PubMed]
18.
Berthon-Jones M, Sullivan CE: Ventilation and arousal responses to hypercapnia in normal sleeping humans. J Appl Physiol 1984;57:59–67.
[PubMed]
19.
Tarrega J, Guell R, Anton A, et al: Are daytime arterial blood gases a good reflection of nighttime gas exchange in patients on long-term oxygen therapy? Respir Care 2002;47:882–886.
[PubMed]
20.
O’Donoghue FJ, Catcheside PG, Eckert DJ, McEvoy RD: Changes in respiration in NREM sleep in hypercapnic chronic obstructive pulmonary disease. J Physiol 2004;559:663–673.
[PubMed]
21.
Siafakas NM, Vermeire P, Pride NB, et al: Optimal assessment and management of chronic obstructive pulmonary disease (COPD): the European Respiratory Society Task Force. Eur Respir J 1995;8:1398–1420.
[PubMed]
22.
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995;152:S77–S121.
23.
Sanchez AL, Cornudella R, Estopa MR, Molinos ML, Servera PE: Guidelines for indications and use of domiciliary continuous oxygen (DCO) therapy: SEPAR guidelines (in Spanish). Arch Bronconeumol 1998;34:87–94.
[PubMed]
24.
Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667–689.
[PubMed]
25.
Goldstein RS, Ramcharan V, Bowes G, McNicholas WT, Bradley D, Phillipson EA: Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med 1984;310:425–429.
[PubMed]
26.
O’Donoghue FJ, Catcheside PG, Ellis EE, et al: Sleep hypoventilation in hypercapnic chronic obstructive pulmonary disease: prevalence and associated factors. Eur Respir J 2003;21:977–984.
[PubMed]
27.
Dempsey JA, Reddan W, Balke B, Rankin J: Work capacity determinants and physiologic cost of weight-supported work in obesity. J Appl Physiol 1966;21:1815–1820.
[PubMed]
28.
Burki NK, Baker RW: Ventilatory regulation in eucapnic morbid obesity. Am Rev Respir Dis 1984;129:538–543.
[PubMed]
29.
Gottlieb DJ, Whitney CW, Bonekat WH, et al: Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med 1999;159:502–507.
[PubMed]
30.
Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A: Effects of age on sleep apnea in men. I. Prevalence and severity. Am J Respir Crit Care Med 1998;157:144–148.
[PubMed]
31.
Redline S, Schluchter MD, Larkin EK, Tishler PV: Predictors of longitudinal change in sleep-disordered breathing in a nonclinic population. Sleep 2003;26:703–709.
[PubMed]
32.
Schonhofer B, Wenzel M, Geibel M, Kohler D: Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med 1998;26:1824–1828.
[PubMed]
33.
Marrades RM, Diaz O, Roca J, et al: Adjustment of DLCO for hemoglobin concentration. Am J Respir Crit Care Med 1997;155:236–241.
[PubMed]
34.
Collard P, Wilputte JY, Aubert G, Rodenstein DO, Frans A: The single-breath diffusing capacity for carbon monoxide in obstructive sleep apnea and obesity. Chest 1996;110:1189–1193.
[PubMed]
35.
Anton A, Guell R: Home mechanical ventilation in COPD: do we know when and how to use it? Chest 2000;118:1525–1526.
[PubMed]
36.
McEvoy RD, Pierce RJ, Hillman D, et al: Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax 2009;64:561–566.
[PubMed]
37.
Clini EM, Magni G, Crisafulli E, Viaggi S, Ambrosino N: Home non-invasive mechanical ventilation and long-term oxygen therapy in stable hypercapnic chronic obstructive pulmonary disease patients: comparison of costs. Respiration 2009;77:44–50.
[PubMed]
© 2010 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2010
You do not currently have access to this content.
